chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspepsia, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Severe heartburn; Injection site also itched like crazy; Her injection site also turned puffy; Injection site also turned red; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (Severe heartburn), VACCINATION SITE PRURITUS (Injection site also itched like crazy), VACCINATION SITE SWELLING (Her injection site also turned puffy) and VACCINATION SITE ERYTHEMA (Injection site also turned red) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (unspecified).   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced DYSPEPSIA (Severe heartburn), VACCINATION SITE PRURITUS (Injection site also itched like crazy), VACCINATION SITE SWELLING (Her injection site also turned puffy) and VACCINATION SITE ERYTHEMA (Injection site also turned red). At the time of the report, DYSPEPSIA (Severe heartburn), VACCINATION SITE PRURITUS (Injection site also itched like crazy), VACCINATION SITE SWELLING (Her injection site also turned puffy) and VACCINATION SITE ERYTHEMA (Injection site also turned red) was resolving.            The patient reported that she also woke up in the middle of the night with heartburn again. No relevant concomitant medications were reported.  No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Unevaluable event
Clinical narrative: Delayed getting their second dose of the Moderna COVID-19 vaccine; Did not have a lot of reactions; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Delayed getting their second dose of the Moderna COVID-19 vaccine) and UNEVALUABLE EVENT (Did not have a lot of reactions) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Delayed getting their second dose of the Moderna COVID-19 vaccine) and UNEVALUABLE EVENT (Did not have a lot of reactions). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Delayed getting their second dose of the Moderna COVID-19 vaccine) and UNEVALUABLE EVENT (Did not have a lot of reactions) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Headache, Vertigo, Visual impairment
Clinical narrative: mild vertigo; lag in focus in my vision; felt cold; shivery; headache; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (mild vertigo), VISUAL IMPAIRMENT (lag in focus in my vision), FEELING COLD (felt cold), CHILLS (shivery) and HEADACHE (headache) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VERTIGO (mild vertigo), VISUAL IMPAIRMENT (lag in focus in my vision), FEELING COLD (felt cold), CHILLS (shivery) and HEADACHE (headache). At the time of the report, VERTIGO (mild vertigo), VISUAL IMPAIRMENT (lag in focus in my vision), FEELING COLD (felt cold), CHILLS (shivery) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided by the reporter.  Treatment information was not provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) in a 27-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 09-Aug-2020 and the estimated date of delivery was 25-May-2021. On 29-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fourth week of the pregnancy. The delivery occurred  on 12-Apr-2021, which was reported as Premature. For neonate 1, The outcome was reported as Pre-Term Birth NOS. Intestinal Artesia of the jejunum, water broke 4/5 and baby born 6 weeks early. On 29-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Sep-2020, Pregnancy test: positive (Positive) positive.         No concomitant medications were reported. No treatment medications were reported.   Company Comment: This case concerns a 27 year-old, female patient, who is pregnant (the estimated date of delivery is 25-May-2021) and experienced an event of drug exposure during pregnancy after receiving her first dose of mRNA-1273 vaccine on 29Jan2021 and second dose on 05Mar2021.  No adverse events were reported.  Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up attached on 7 May 2021 and VAERS with outcome of pregnancy; Sender's Comments: This case concerns a 27 year-old, female patient, who is pregnant (the estimated date of delivery is 25-May-2021) and experienced an event of drug exposure during pregnancy after receiving her first dose of mRNA-1273 vaccine on 29Jan2021 and second dose on 05Mar2021.  No adverse events were reported.  Further information has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Product administration interrupted, Product availability issue
Clinical narrative: not received the second dose yet due to product shortage/it has been 49 days since his first dose; not received the second dose yet due to product shortage/it has been 49 days since his first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (not received the second dose yet due to product shortage/it has been 49 days since his first dose) and PRODUCT AVAILABILITY ISSUE (not received the second dose yet due to product shortage/it has been 49 days since his first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (not received the second dose yet due to product shortage/it has been 49 days since his first dose) and PRODUCT AVAILABILITY ISSUE (not received the second dose yet due to product shortage/it has been 49 days since his first dose). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (not received the second dose yet due to product shortage/it has been 49 days since his first dose) and PRODUCT AVAILABILITY ISSUE (not received the second dose yet due to product shortage/it has been 49 days since his first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive, Vaccination site pain
Clinical narrative: Tested positive for Covid, had no symptoms; Pain at the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of ASYMPTOMATIC COVID-19 (Tested positive for Covid, had no symptoms) and VACCINATION SITE PAIN (Pain at the arm of the injection) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at the arm of the injection). On 02-Mar-2021, the patient experienced ASYMPTOMATIC COVID-19 (Tested positive for Covid, had no symptoms). On 12-Feb-2021, VACCINATION SITE PAIN (Pain at the arm of the injection) had resolved. At the time of the report, ASYMPTOMATIC COVID-19 (Tested positive for Covid, had no symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, SARS-CoV-2 test positive: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated that she thought she had Covid some days before she was tested  No concomitant medications were reported.  No treatment information was provided
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding
Clinical narrative: Exposure during breast feeding; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D3, BIFIDOBACTERIUM INFANTIS, LACTOBACILLUS ACIDOPHILUS (PROBIOTIC [BIFIDOBACTERIUM INFANTIS;LACTOBACILLUS ACIDOPHILUS]) and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding). On 10-Mar-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Patient had no side effects were reported after the first dose.; Sender's Comments: This is a case of product exposure during breastfeeding with no associated AEs. Patient will continue to be contacted for further monitoring of AEs.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest discomfort, Chest pain, Nausea
Clinical narrative: had a very strong pain in their chest, near their heart; like a fear or anxiety sensation that comes to their chest; Nausea; This spontaneous case was reported by a physician and describes the occurrence of CHEST PAIN (had a very strong pain in their chest, near their heart), CHEST DISCOMFORT (like a fear or anxiety sensation that comes to their chest) and NAUSEA (Nausea) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 20-Jan-2021. Concomitant products included FENOFIBRATE and ATORVASTATIN for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced CHEST PAIN (had a very strong pain in their chest, near their heart), CHEST DISCOMFORT (like a fear or anxiety sensation that comes to their chest) and NAUSEA (Nausea). On 25-Feb-2021, CHEST PAIN (had a very strong pain in their chest, near their heart) and NAUSEA (Nausea) had resolved. At the time of the report, CHEST DISCOMFORT (like a fear or anxiety sensation that comes to their chest) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Blood pressure measurement: 150 mmHg High and 127 mmHg Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 20-Jan-2021, the patient was tested positive for COVID. On 31-Jan-2021 the patient's quarantine was over and on 08-Feb-2021 the patient was feeling better.  On 25-Feb-2021, the patient was taken to the hospital to rule out that he had a heart attack. The patient's studies were normal. After the vaccination the patient had been left with a sensation, like a fear or anxiety sensation that comes to his chest. When the patient was doing activities he forgot and it was gone, but suddenly when he was in calm on their house that sensation came back.  Treatment medication include Ondansetron. The patient was given something else in the ambulance, it was a spray, they don't know what it was but they suppose it was something to control their blood pressure since it was in 127 when they got to the hospital.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: arm soreness; temperature which has been on/off; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and PYREXIA (temperature which has been on/off) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness) and PYREXIA (temperature which has been on/off). At the time of the report, PAIN IN EXTREMITY (arm soreness) and PYREXIA (temperature which has been on/off) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Hot flush
Clinical narrative: Dizzy and lightheaded / cannot bend due to dizziness; Hot flashes; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy and lightheaded / cannot bend due to dizziness), HOT FLUSH (Hot flashes) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced CHILLS (Chills). On 07-Mar-2021, the patient experienced DIZZINESS (Dizzy and lightheaded / cannot bend due to dizziness) and HOT FLUSH (Hot flashes). On 06-Mar-2021, CHILLS (Chills) had resolved. On 07-Mar-2021, HOT FLUSH (Hot flashes) had resolved. At the time of the report, DIZZINESS (Dizzy and lightheaded / cannot bend due to dizziness) was resolving.            No concomitant medications were provided.  Treatment details was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Headache, Vaccination complication
Clinical narrative: Upset Stomach; Listedness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Upset Stomach), VACCINATION COMPLICATION (Listedness) and HEADACHE (Headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included LOSARTAN and VITAMINS NOS for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Upset Stomach), VACCINATION COMPLICATION (Listedness) and HEADACHE (Headache). At the time of the report, ABDOMINAL DISCOMFORT (Upset Stomach), VACCINATION COMPLICATION (Listedness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Hyperhidrosis
Clinical narrative: Sweats", "soaking all on day 5 after shot; Diarrhea; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats", "soaking all on day 5 after shot), DIARRHOEA (Diarrhea) and FATIGUE (Felt tired) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Viral infection in April 2021. Concomitant products included LISINOPRIL, VITAMIN D3, ACETYLSALICYLIC ACID (ASPIRIN 81), CARBAMAZEPINE (TEGRETOL) and ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweats", "soaking all on day 5 after shot), DIARRHOEA (Diarrhea) and FATIGUE (Felt tired). At the time of the report, HYPERHIDROSIS (Sweats", "soaking all on day 5 after shot) and DIARRHOEA (Diarrhea) was resolving and FATIGUE (Felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated that previously, near month ago, she had some unknown viral infection and felt herself closely to these events.  Treatment information was not provided.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Rash was itchy all over body; Severe rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Rash was itchy all over body) and RASH (Severe rash all over body) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL) and CROTAMITON (ANTI ITCH CREAM [CROTAMITON]) for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (Rash was itchy all over body) and RASH (Severe rash all over body). At the time of the report, PRURITUS (Rash was itchy all over body) and RASH (Severe rash all over body) had not resolved.            Treatment for the event includes Benadryl and anti itch cream for rash.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: High grade fever; Headache; Bodyache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High grade fever), HEADACHE (Headache) and MYALGIA (Bodyache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in August 2020. Concurrent medical conditions included Blood pressure high. Concomitant products included CANDESARTAN for Blood pressure high.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PYREXIA (High grade fever), HEADACHE (Headache) and MYALGIA (Bodyache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PYREXIA (High grade fever), HEADACHE (Headache) and MYALGIA (Bodyache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medication included statin for blood pressure.  Treatment medications taken were acetaminophen (Tylenol) and ibuprofen (Advil).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Cough, Pyrexia
Clinical narrative: back pain; cough; felt like she had a fever; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), COUGH (cough) and PYREXIA (felt like she had a fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 029L20A) for COVID-19 immunisation.     No medical history was reported.  Concomitant products included METFORMIN HCL, LISINOPRIL, AMLODIPINE, CEFIXIME (FLEXERIL [CEFIXIME]), SPIRONOLACTONE, FUROSEMIDE, POTASSIUM CHLORIDE (LASIX + K), LINAGLIPTIN (TRADJENTA), SIMVASTATIN, LORATADINE, LINACLOTIDE (LINZESS), MAGNESIUM, VITAMIN B COMPLEX (SUPER B COMPLEX [VITAMIN B COMPLEX]), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), INSULIN and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced BACK PAIN (back pain), COUGH (cough) and PYREXIA (felt like she had a fever). At the time of the report, BACK PAIN (back pain), COUGH (cough) and PYREXIA (felt like she had a fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 97.6 f Inconclusive.         Treatment medication included cough drops (unspecified).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: swelling of her left foot/tremendous swelling in left hand; diarrhea; difficulty sleeping; chills; headache; fatigue; muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling of her left foot/tremendous swelling in left hand), DIARRHOEA (diarrhea), INSOMNIA (difficulty sleeping), CHILLS (chills) and HEADACHE (headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder and Anxiety. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), IRON, POLYCARBOPHIL CALCIUM (FIBER), VITAMIN C [ASCORBIC ACID], VITAMIN D [VITAMIN D NOS] and TRAMADOL HYDROCHLORIDE (TREMADOL) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PERIPHERAL SWELLING (swelling of her left foot/tremendous swelling in left hand), DIARRHOEA (diarrhea), INSOMNIA (difficulty sleeping), CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, PERIPHERAL SWELLING (swelling of her left foot/tremendous swelling in left hand), DIARRHOEA (diarrhea), INSOMNIA (difficulty sleeping), CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medications included water pill, thyroid medications and anxiety medications (unspecified).  Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Myalgia, Peripheral swelling
Clinical narrative: swelling of her left foot/tremendous swelling in left hand; diarrhea; difficulty sleeping; chills; headache; fatigue; muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling of her left foot/tremendous swelling in left hand), DIARRHOEA (diarrhea), INSOMNIA (difficulty sleeping), CHILLS (chills) and HEADACHE (headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder and Anxiety. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), IRON, POLYCARBOPHIL CALCIUM (FIBER), VITAMIN C [ASCORBIC ACID], VITAMIN D [VITAMIN D NOS] and TRAMADOL HYDROCHLORIDE (TREMADOL) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PERIPHERAL SWELLING (swelling of her left foot/tremendous swelling in left hand), DIARRHOEA (diarrhea), INSOMNIA (difficulty sleeping), CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, PERIPHERAL SWELLING (swelling of her left foot/tremendous swelling in left hand), DIARRHOEA (diarrhea), INSOMNIA (difficulty sleeping), CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medications included water pill, thyroid medications and anxiety medications (unspecified).  Treatment information was not provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Mouth swelling
Clinical narrative: the mouth just swelled up; it was a very funny feeling, a weird sensation; This spontaneous case was reported by a consumer and describes the occurrence of MOUTH SWELLING (the mouth just swelled up) and FEELING ABNORMAL (it was a very funny feeling, a weird sensation) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced MOUTH SWELLING (the mouth just swelled up) and FEELING ABNORMAL (it was a very funny feeling, a weird sensation). At the time of the report, MOUTH SWELLING (the mouth just swelled up) and FEELING ABNORMAL (it was a very funny feeling, a weird sensation) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient received treatment with homeopathic- rescue remedy and it seemed to calm down the symptoms.  Reportedly, the patient stated that the swelling happened right away and it began to go down within a fairly short period of time. The patient stated that it didn't go down to the throat and that she has been in getting in touch with her .doctor she is concerned about second dose.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow up information received on 02-JUL-2021 and contains non significant information: Contact information updated- email address and fax number added.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Sinus headache
Clinical narrative: Severe sinus headache; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of SINUS HEADACHE (Severe sinus headache) and COUGH (Coughing) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE, PARACETAMOL (TYLENOL) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUS HEADACHE (Severe sinus headache) and COUGH (Coughing). At the time of the report, SINUS HEADACHE (Severe sinus headache) and COUGH (Coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol and Benadryl.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, COVID-19, Chills, Cough
Clinical narrative: Tested positive for COVID19 Virus; Weak; Chills; Body aches; Headache; Backache; Cough; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), COUGH (Cough), SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus), ASTHENIA (Weak) and CHILLS (Chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Heart disorder. Concomitant products included LEVOTHYROXINE and PANTOPRAZOLE for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced BACK PAIN (Backache), COUGH (Cough), ASTHENIA (Weak), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headache). On 17-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 26-Feb-2021, BACK PAIN (Backache), COUGH (Cough), ASTHENIA (Weak), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headache) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient went to Jacobi Hospital and received antiviral IVE Bamlanivimab and IV infusion for testing CVOID-19 positive. The patient was quarantined for 14 days. The treatment medications given were cough syrup and Extra strength Tylenol.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID19 Virus; Weak; Chills; Body aches; Headache; Backache; Cough; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), COUGH (Cough), SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus), ASTHENIA (Weak) and CHILLS (Chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Heart disorder. Concomitant products included LEVOTHYROXINE and PANTOPRAZOLE for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced BACK PAIN (Backache), COUGH (Cough), ASTHENIA (Weak), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headache). On 17-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 26-Feb-2021, BACK PAIN (Backache), COUGH (Cough), ASTHENIA (Weak), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headache) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID19 Virus) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient went to Jacobi Hospital and received antiviral IVE Bamlanivimab and IV infusion for testing CVOID-19 positive. The patient was quarantined for 14 days. The treatment medications given were cough syrup and Extra strength Tylenol.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A(or D) and 012M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved.            No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Erythema, Pruritus
Clinical narrative: Itch has gotten worse; Redness that is spread all the way up to shoulder, up to 6-8 inches; Arm started itching, itching is not stopping; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Itch has gotten worse), ERYTHEMA (Redness that is spread all the way up to shoulder, up to 6-8 inches) and PRURITUS (Arm started itching, itching is not stopping) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (Itch has gotten worse), ERYTHEMA (Redness that is spread all the way up to shoulder, up to 6-8 inches) and PRURITUS (Arm started itching, itching is not stopping). At the time of the report, CONDITION AGGRAVATED (Itch has gotten worse), ERYTHEMA (Redness that is spread all the way up to shoulder, up to 6-8 inches) and PRURITUS (Arm started itching, itching is not stopping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Patient called  doctor's office and had telemedicine appointment with the physician's assistant who offered topical antihistamine prescription but patient denied as it has never helped the patient in the past.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Depressed mood, Fatigue, Headache
Clinical narrative: Just moped around the house for the day; Woke up tired; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSED MOOD (Just moped around the house for the day), FATIGUE (Woke up tired) and HEADACHE (Slight headache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced DEPRESSED MOOD (Just moped around the house for the day), FATIGUE (Woke up tired) and HEADACHE (Slight headache). On 24-Jan-2021, DEPRESSED MOOD (Just moped around the house for the day), FATIGUE (Woke up tired) and HEADACHE (Slight headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. The patient did not receive any treatment.  The patient received the second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) on 17-Feb-2021.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Fatigue, Headache, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bones were in pain), VACCINATION SITE WARMTH (red and hot rash on injection site), VACCINATION SITE ERYTHEMA (red and hot rash on injection site), VACCINATION SITE RASH (red and hot rash on injection site) and NAUSEA (nausea) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BONE PAIN (bones were in pain), VACCINATION SITE WARMTH (red and hot rash on injection site), VACCINATION SITE ERYTHEMA (red and hot rash on injection site), VACCINATION SITE RASH (red and hot rash on injection site), NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (headache) and CHILLS (body chills). At the time of the report, BONE PAIN (bones were in pain), VACCINATION SITE WARMTH (red and hot rash on injection site), VACCINATION SITE ERYTHEMA (red and hot rash on injection site), VACCINATION SITE RASH (red and hot rash on injection site), NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (headache) and CHILLS (body chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter.  Treatment information included ibuprofen (Advil).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bones were in pain), VACCINATION SITE WARMTH (red and hot rash on injection site), VACCINATION SITE ERYTHEMA (red and hot rash on injection site), VACCINATION SITE RASH (red and hot rash on injection site) and NAUSEA (nausea) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BONE PAIN (bones were in pain), VACCINATION SITE WARMTH (red and hot rash on injection site), VACCINATION SITE ERYTHEMA (red and hot rash on injection site), VACCINATION SITE RASH (red and hot rash on injection site), NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (headache) and CHILLS (body chills). At the time of the report, BONE PAIN (bones were in pain), VACCINATION SITE WARMTH (red and hot rash on injection site), VACCINATION SITE ERYTHEMA (red and hot rash on injection site), VACCINATION SITE RASH (red and hot rash on injection site), NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (headache) and CHILLS (body chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter.  Treatment information included ibuprofen (Advil).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash, Urticaria, Vaccination site pruritus
Clinical narrative: Blisters on arm, hand, big toe; Rash; Bumps on hand; Arm below injection site is itchy; Bump in palm of hand/looked like a hive; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Bump in palm of hand/looked like a hive), BLISTER (Blisters on arm, hand, big toe), URTICARIA (Bumps on hand), VACCINATION SITE PRURITUS (Arm below injection site is itchy) and RASH (Rash) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced URTICARIA (Bump in palm of hand/looked like a hive). On 10-Mar-2021, the patient experienced URTICARIA (Bumps on hand) and VACCINATION SITE PRURITUS (Arm below injection site is itchy). On an unknown date, the patient experienced BLISTER (Blisters on arm, hand, big toe) and RASH (Rash). At the time of the report, URTICARIA (Bump in palm of hand/looked like a hive) had resolved, BLISTER (Blisters on arm, hand, big toe), URTICARIA (Bumps on hand) and RASH (Rash) outcome was unknown and VACCINATION SITE PRURITUS (Arm below injection site is itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product information was reported.  Patient's treatment information include diphenhydramine (Benadryl) lotion on rash. The patient reported that the bump looked like a hive and then it flattened out. On 10-Mar-2021, everything broke out.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass, Pain in extremity, Vaccination site lymphadenopathy
Clinical narrative: Sore arm; She felt a lump under her neck,  she can't see by looking but she can feel it; Lymph node under her arm swollen at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK MASS (She felt a lump under her neck,  she can't see by looking but she can feel it), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE LYMPHADENOPATHY (Lymph node under her arm swollen at the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 immunisation.     Concurrent medical conditions included Type II diabetes mellitus and Hypertension. Concomitant products included METFORMIN for Blood pressure high.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Lymph node under her arm swollen at the injection site). On 09-Mar-2021, the patient experienced NECK MASS (She felt a lump under her neck,  she can't see by looking but she can feel it). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, NECK MASS (She felt a lump under her neck,  she can't see by looking but she can feel it), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE LYMPHADENOPATHY (Lymph node under her arm swollen at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: patient reports following up with HCP and states "everything is okay"
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: Sore arm; Chills; Headache; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Tired) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Tired). On 09-Mar-2021, PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Consumer does not have an email or fax number to provide, stated Is feeling fine' and has no additional information to report.
Sex: U
Vaccine: COVID19
Symptoms: Neutrophil count, Neutrophil count decreased, White blood cell count, White blood cell count decreased
Clinical narrative: low white blood cell; low neutrophil count; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of WHITE BLOOD CELL COUNT DECREASED (low white blood cell) and NEUTROPHIL COUNT DECREASED (low neutrophil count) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WHITE BLOOD CELL COUNT DECREASED (low white blood cell) and NEUTROPHIL COUNT DECREASED (low neutrophil count). At the time of the report, WHITE BLOOD CELL COUNT DECREASED (low white blood cell) and NEUTROPHIL COUNT DECREASED (low neutrophil count) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Neutrophil count: low (Low) Low. On an unknown date, White blood cell count: low (Low) low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.